Point of Care Testing in Pediatric Patients Undergoing Major Surgery
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01742936 |
|
Recruitment Status :
Completed
First Posted : December 6, 2012
Results First Posted : June 8, 2016
Last Update Posted : August 25, 2016
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Spinal Fusion Cardiopulmonary Bypass | Device: CoaguChek Other: Hospital Laboratory | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 100 participants |
| Allocation: | Non-Randomized |
| Intervention Model: | Single Group Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Diagnostic |
| Official Title: | Point of Care Testing for Coagulation Function Versus Standard Laboratory Testing in Pediatric Patients Undergoing Major Surgery |
| Study Start Date : | February 2013 |
| Actual Primary Completion Date : | January 2015 |
| Actual Study Completion Date : | January 2015 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Spinal fusion
Patients undergoing a posterior spinal fusion and having clotting factors checked by both hand held CoaguChek and Hospital Laboratory.
|
Device: CoaguChek
Hand held coagulation monitor. Other: Hospital Laboratory Coagulation testing done by hospital laboratory. |
|
Experimental: Cardiac bypass
Patients undergoing surgery requiring cardiopulmonary bypass and having clotting factors checked by both hand held CoaguChek and Hospital Laboratory.
|
Device: CoaguChek
Hand held coagulation monitor. Other: Hospital Laboratory Coagulation testing done by hospital laboratory. |
- International Normalized Ratio (INR) on CoaguChek [ Time Frame: At end of surgery (an average of 2-4 hrs for cardiac bypass and 4-6 hrs. for spinal fusion) ]Measuring the blood's ability to clot on a handheld monitor.
- International Normalized Ratio (INR) Performed by Hospital Laboratory [ Time Frame: At end of surgery (an average of 2-4 hrs for cardiac bypass and 4-6 hrs. for spinal fusion) ]Measuring the bloods ability to clot by the hospital's reference laboratory.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 2 Years to 18 Years (Child, Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Undergoing elective posterior spinal fusion surgery at Nationwide Children's Hospital
- Parents willing & able to provide informed consent
- Child able to provide assent (if age appropriate)
Exclusion Criteria:
- Pre-existing bleeding disorders
- Any other circumstance which, in the opinion of the investigator, would put the patient at increased risk.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01742936
| United States, Ohio | |
| Nationwide Children's Hospital | |
| Columbus, Ohio, United States, 43205 | |
| Responsible Party: | Vidya Raman, Director of Preoperative Assessment Testing, Nationwide Children's Hospital |
| ClinicalTrials.gov Identifier: | NCT01742936 |
| Other Study ID Numbers: |
IRB12-00762 |
| First Posted: | December 6, 2012 Key Record Dates |
| Results First Posted: | June 8, 2016 |
| Last Update Posted: | August 25, 2016 |
| Last Verified: | July 2016 |

